Across Canada, healthcare providers are carefully modifying their approaches to BZD administration following the release of recent guidelines. These directives aim to reduce the risks associated with long-term use and addiction, highlighting the critical need of comprehensive patient evaluations and investigating alternative therapy possibilities.